Olympia Pharmaceuticals
Olympia Pharmaceuticals is an FDA-registered 503B outsourcing facility and affiliated 503A compounding pharmacy in Orlando, Florida. It manufactures pharmaceutical-grade compounded medications—IV therapy, peptides, hormones, and longevity formulations—and distributes them to healthcare providers, clinics, and pharmacies nationwide, alongside sister brand Wesley Pharmaceuticals.
- Company typePrivate
- Founded2009
- HeadquartersOrlando, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
Olympia Pharmaceuticals firmographics
Firmographics- Name
- Olympia Pharmaceuticals
- Legal name
- Olympia Pharmaceuticals
- Website
- https://olympiapharmacy.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Olympia Pharmaceuticals is an FDA-registered 503B outsourcing facility and affiliated 503A compounding pharmacy in Orlando, Florida. It manufactures pharmaceutical-grade compounded medications—IV therapy, peptides, hormones, and longevity formulations—and distributes them to healthcare providers, clinics, and pharmacies nationwide, alongside sister brand Wesley Pharmaceuticals.
- Ownership category
- akta.pro rank
Olympia Pharmaceuticals industry classification
Industry- Product category
- Compounding Pharmacy Services
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmacies and Drug Retailers (456110)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Infusion & Home Infusion Pharmacy Services (HLAFALAG)
- akta.pro secondary industries
- Hospital & Health-System Pharmacies (Inpatient/Outpatient) (HLAFALAB), Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ), Specialty Pharmacy & Biologics Distribution (CRAOAHAD)
Keywords
Where Olympia Pharmaceuticals is headquartered
LocationHeadquarters
- HQ city
- Orlando
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Olympia Pharmaceuticals business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- 503B Compounding (Office Use): Sale of FDA-registered 503B outsourcing facility compounded medications for office use to healthcare providers, clinics, and medical practices nationwide
- 503A Prescription Fulfillment: Prescription-based medication fulfillment through affiliated Olympia Pharmacy, delivering compounded medications directly to patients via their healthcare providers
- Consumer Wellness Products: Direct-to-consumer wellness products including OlympiaGO hydration drink mixes and OTC nutritional supplements
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | B2B pricing for healthcare providers |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels12 records
Olympia Pharmaceuticals product offering
Product offeringCore offering
Olympia Pharmaceuticals operates as a dual-entity pharmaceutical compounding organization: a 503B FDA-registered outsourcing facility that manufactures large-batch sterile compounded medications for office use, and an affiliated 503A state-licensed pharmacy that fulfills individual prescriptions for patients via healthcare providers. Its portfolio spans IV nutritional therapy premixes, peptide injections, hormone replacement, weight management injectables, longevity products (NAD+, Liquid Niagen), sexual health compounds, and consumer wellness hydration drink mixes (OlympiaGO).
Product overview
Olympia Pharmaceuticals operates as a dual-entity pharmacy organization consisting of a 503B FDA-registered outsourcing facility and an affiliated 503A compounding pharmacy. The company provides pharmaceutical-grade compounded medications across multiple therapeutic categories including longevity/anti-aging (NAD+ Injection, Liquid Niagen), weight management (Lipo-Mino-Mix, Lipo+, LipoStat-Plus injections, Naltrexone, Liraglutide, PeptideVite), IV nutritional therapy (Myers Cocktail, Tri-Immune Boost, Olympia Vita-Complex, Circulate), sexual health (TriMix), peptides (Sermorelin), vitamins (B12, B6, Biotin), minerals (Zinc, Magnesium, Calcium), amino acids (Glutamine, Lysine, Taurine, Arginine), and consumer wellness products (OlympiaGO hydration sticks). The 503B facility produces medications for office use with cGMP compliance, while the 503A pharmacy fulfills prescriptions directly to patients through healthcare providers. The company also partners with sister brand Wesley Pharmaceuticals for expanded distribution.
Differentiator
Problem solved
Functional benefit
Products and services
- 503B Compounding Services
Quantifiable outcome
- Next-day delivery to most of Florida
- +2 more outcomes
Companies that use Olympia Pharmaceuticals
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles4 records
Olympia Pharmaceuticals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Olympia Pharmaceuticals partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Niagen BiosciencecoreNiagen Bioscience partnered with Olympia Pharmaceuticals as a 503B compounding partner to compound and distribute pharmaceutical-grade Niagen for its Niagen Plus intravenous and injectable products. The partnership diversifies Niagen Bioscience's 503B network beyond existing partner Wells Pharma of Houston, expanding supply chain capabilities to support growth across clinic footprint nationwide. The collaboration addresses growing demand for Niagen IV and injections in the healthy aging and longevity market.
- Wesley PharmaceuticalscoreWesley Pharmaceuticals is a Florida-based 503B outsourcing facility and sister company of Olympia Pharmaceuticals. Olympia supplies products from its existing portfolio to Wesley, which distributes through its nationwide client network. Wesley launched NAD+ sourced from Olympia's portfolio, expanding access to compounded wellness products within Olympia's ecosystem. Wesley is currently licensed in 29 states with further expansion planned throughout 2026.
- Wells Pharma of HoustonminorExisting 503B compounding network partner of Niagen Bioscience. Olympia Pharmaceuticals joined the network alongside Wells Pharma, providing additional manufacturing and distribution capacity.
Scale indicators3 records
Recent moves10 records
Expansion highlights6 records
Olympia Pharmaceuticals competitors and assessment
Company assessmentDirect peers
- Fagron: Global leader in pharmaceutical compounding with significant 503B and 503A operations in the U.S. Direct competitor to Olympia in sterile injectable and office-use compounded medications, with overlapping product categories including hormones, peptides, and IV therapy.
- QuVa Pharma: One of the largest FDA-registered 503B outsourcing facilities in the U.S., specializing in sterile injectable compounded medications for hospitals and clinics. Directly comparable to Olympia's 503B office-use business, particularly in the sterile injectable and IV therapy categories Olympia serves.
- Anazao Health: Specialty compounding pharmacy offering both 503A patient-specific prescriptions and 503B office-use sterile products. Comparable to Olympia across the dual 503A/503B model, with overlapping therapies in hormone replacement, IV nutrition, and wellness.
- Wells Pharma of Houston: FDA-registered 503B outsourcing facility explicitly named as a 503B compounding network partner of Niagen Bioscience alongside Olympia. Direct competitor in sterile injectable compounding and the same Niagen Plus product line Olympia now produces.
- SCA Pharma: 503B outsourcing facility specializing in sterile admixtures and pre-filled syringes for hospital and clinic use. Comparable to Olympia's 503B business in customer base (hospitals/clinics) and regulatory profile (cGMP, FDA-registered).
- Leiters Health: FDA-registered 503B outsourcing facility producing ready-to-administer sterile injectable medications, with overlap to Olympia's office-use product set including ophthalmic, analgesic, and surgical compounds. Operates at a comparable cGMP-compliance tier.
- Edge Pharma: FDA-registered 503B outsourcing facility producing sterile injectable compounded medications, with a focus on ophthalmic, inhalation, and injectable products for hospitals. Comparable to Olympia in cGMP sterile injectable compounding and the office-use sales channel.
Broad incumbents
- Central Admixture Pharmacy Services (CAPS / B. Braun): One of the largest 503B outsourcing networks in the U.S., owned by B. Braun. Overlaps with Olympia's 503B sterile compounding business but operates at significantly larger scale across hospitals and health systems.
Emerging players
- Triangle Compounding Pharmacy: Specialty compounding pharmacy with a 503B-sterile program, focused on hormone replacement, peptides, and weight management. Comparable to Olympia in therapeutic-category mix but operates at smaller scale and primarily regional footprint.
- Alto Pharmacy: Tech-enabled specialty and compounding pharmacy with prescription fulfillment directly to patients. Partially comparable to Olympia's 503A direct-to-patient prescription fulfillment channel and automated refill service, though primarily a tech/retail pharmacy rather than a 503B outsourcer.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Olympia Pharmaceuticals social profiles
Digital presenceOlympia Pharmaceuticals compliance and trust
Trust signalCompliance4 records
Olympia Pharmaceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
Olympia Pharmaceuticals leadership team
Management profileNumber of profiles
Profiles5 records
Olympia Pharmaceuticals funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Olympia Pharmaceuticals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Olympia Pharmaceuticals
What does Olympia Pharmaceuticals do?
Olympia Pharmaceuticals operates as a dual-entity pharmaceutical compounding organization: a 503B FDA-registered outsourcing facility that manufactures large-batch sterile compounded medications for office use, and an affiliated 503A state-licensed pharmacy that fulfills individual prescriptions for patients via healthcare providers. Its portfolio spans IV nutritional therapy premixes, peptide injections, hormone replacement, weight management injectables, longevity products (NAD+, Liquid Niagen), sexual health compounds, and consumer wellness hydration drink mixes (OlympiaGO).
Is Olympia Pharmaceuticals a public or private company?
Olympia Pharmaceuticals is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Olympia Pharmaceuticals founded?
Olympia Pharmaceuticals was founded in 2009. It employs 101 to 250 people.
Where is Olympia Pharmaceuticals based?
Olympia Pharmaceuticals is headquartered in Orlando, United States, in the North America region.
How does Olympia Pharmaceuticals make money?
Three revenue lines are on record. 503B Compounding (Office Use) is the primary driver. The others are 503A Prescription Fulfillment and consumer Wellness Products.
Who are Olympia Pharmaceuticals's main competitors?
Direct peers on record are Fagron, QuVa Pharma, Anazao Health, Wells Pharma of Houston, SCA Pharma, Leiters Health and Edge Pharma. Central Admixture Pharmacy Services (CAPS / B. Braun) is listed as a broad incumbent. Emerging players are Triangle Compounding Pharmacy and Alto Pharmacy.
Does Olympia Pharmaceuticals have an API?
No public API is recorded for Olympia Pharmaceuticals.
What industry is Olympia Pharmaceuticals in?
Olympia Pharmaceuticals's product category is Compounding Pharmacy Services. Its primary akta.pro industry code is HLAFALAG, Infusion & Home Infusion Pharmacy Services, with a secondary code of HLAFALAB, Hospital & Health-System Pharmacies (Inpatient/Outpatient). Its NAICS code is 325412 and its SIC code is 2834.